Literature DB >> 1372819

Metastasis to the penis from malignant melanoma: case report and review of the literature.

S M Sagar1, S Retsas.   

Abstract

A case of metastatic malignant melanoma to the shaft of the penis is described and the literature reviewed to collate the incidence of primary sites which metastasize to the penis. Less than 260 cases of metastasis to the penis have been reported. Of these, 76% are from genitourinary primary sites and 17% are from gastrointestinal primary sites but only one case of metastatic melanoma to the penis has been previously reported. The described case presented with painful priapism while receiving combination chemotherapy for metastatic disease. A CT scan demonstrated a deposit in the left corpora cavernosa and needle aspiration cytology of a plaque attached to the shaft confirmed malignant melanoma cells. Palliation of the painful priapism was achieved by treatment with radiotherapy using large doses per fraction. Retrograde venous or lymphatic spread may have been the cause of a metastasis at this site. Prognosis is very poor.

Entities:  

Mesh:

Year:  1992        PMID: 1372819     DOI: 10.1016/s0936-6555(05)80985-9

Source DB:  PubMed          Journal:  Clin Oncol (R Coll Radiol)        ISSN: 0936-6555            Impact factor:   4.126


  3 in total

1.  Magnetic resonance imaging (MRI) in penile metastases of extragenitourinary cancers.

Authors:  Tuba Kendi; Ertan Batislam; M Murad Basar; Erdal Yilmaz; Deniz Altinok; Halil Basar
Journal:  Int Urol Nephrol       Date:  2006       Impact factor: 2.370

Review 2.  A review of penile metastasis.

Authors:  Luigi Mearini; Renato Colella; Alessandro Zucchi; Elisabetta Nunzi; Carlo Porrozzi; Massimo Porena
Journal:  Oncol Rev       Date:  2012-06-14

3.  Penile metastasis of urothelial carcinoma diagnosed by fine-needle aspiration.

Authors:  Gilda da Cunha Santos; Marcia Lanzoni de Alvarenga; Vinicius Freitas Borlot; Michel Antonio Kiyota Moutinho; Marcello Fabiano de Franco
Journal:  Cytojournal       Date:  2009-06-18       Impact factor: 2.091

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.